Submit Deal

PROPELLA THERAPEUTICS

Summary

Propella is a privately held development stage company dedicated to bringing to market best-in-class drugs that utilize an active ingredient with a known mechanism of action.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 138 M

Avg. Deal Size£ 138 M

Market Context

Senior Management

William Moore
President and CEO
Brendan Griffin
CFO
George Cox
CLO

Sort

15 Nov 2023|United States|Pharmaceuticals

Target: PROPELLA THERAPEUTICS

Bidder: ASTELLAS PHARMA INC

6 Service Providers

3 Target | 3 Bidder

41 Dealmakers

35 Target | 6 Bidder

£ 137 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy